Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases

Detalhes bibliográficos
Autor(a) principal: Herbster, Suellen
Data de Publicação: 2019
Outros Autores: Paladino, Andressa, Freitas, Sumara de, Boccardo, Enrique
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/154798
Resumo: Infection with human papillomaviruses is associated with a series of benign and malignant hyperproliferative diseases that impose a heavy burden on human populations. A subgroup of mucosal human papillomavirus types are associated with the majority of cervical cancers and a relevant fraction of vulvar, vaginal, anal, penile and head and neck carcinomas. Human papillomaviruses mediate cell transformation by the expression of two pleiotropic oncoproteins that alter major cellular regulatory pathways. However, these viruses are not complete carcinogens, and further alterations within the infected cells and in their microenvironment are necessary for tumor establishment and progression. Alterations in components of the extracellular matrix for instance, matrix metalloproteinases and some of their regulators such as tissue inhibitors of metalloproteinases, have been consistently reported in human papillomaviruses-associated diseases. Matrix metalloproteinases function by remodeling the extracellular matrix and alterations in their expression levels and/or activity are associated with pathological processes and clinical variables including local tumor invasion, metastasis, tumor relapse and overall patient prognosis and survival. In this review we present a summarized discussion on the current data concerning the impact of human papillomavirus infection on the activity and expression of extracellular matrix components. We further comment on the possibility of targeting extracellular matrix molecules in experimental treatment protocols.
id USP-19_686e8ed25698cb2ce9b883a3e324bf50
oai_identifier_str oai:revistas.usp.br:article/154798
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseasesHuman papillomavirusExtracellular matrixMatrix MetalloproteinasesTIMPsRECKInfection with human papillomaviruses is associated with a series of benign and malignant hyperproliferative diseases that impose a heavy burden on human populations. A subgroup of mucosal human papillomavirus types are associated with the majority of cervical cancers and a relevant fraction of vulvar, vaginal, anal, penile and head and neck carcinomas. Human papillomaviruses mediate cell transformation by the expression of two pleiotropic oncoproteins that alter major cellular regulatory pathways. However, these viruses are not complete carcinogens, and further alterations within the infected cells and in their microenvironment are necessary for tumor establishment and progression. Alterations in components of the extracellular matrix for instance, matrix metalloproteinases and some of their regulators such as tissue inhibitors of metalloproteinases, have been consistently reported in human papillomaviruses-associated diseases. Matrix metalloproteinases function by remodeling the extracellular matrix and alterations in their expression levels and/or activity are associated with pathological processes and clinical variables including local tumor invasion, metastasis, tumor relapse and overall patient prognosis and survival. In this review we present a summarized discussion on the current data concerning the impact of human papillomavirus infection on the activity and expression of extracellular matrix components. We further comment on the possibility of targeting extracellular matrix molecules in experimental treatment protocols.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2019-02-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/15479810.6061/clinics/2018/e551sClinics; Vol. 73 No. Suppl. 1 (2018); e551sClinics; v. 73 n. Suppl. 1 (2018); e551sClinics; Vol. 73 Núm. Suppl. 1 (2018); e551s1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/154798/150792Copyright (c) 2019 Clinicsinfo:eu-repo/semantics/openAccessHerbster, SuellenPaladino, AndressaFreitas, Sumara deBoccardo, Enrique2019-05-14T11:48:25Zoai:revistas.usp.br:article/154798Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2019-05-14T11:48:25Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
title Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
spellingShingle Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
Herbster, Suellen
Human papillomavirus
Extracellular matrix
Matrix Metalloproteinases
TIMPs
RECK
title_short Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
title_full Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
title_fullStr Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
title_full_unstemmed Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
title_sort Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
author Herbster, Suellen
author_facet Herbster, Suellen
Paladino, Andressa
Freitas, Sumara de
Boccardo, Enrique
author_role author
author2 Paladino, Andressa
Freitas, Sumara de
Boccardo, Enrique
author2_role author
author
author
dc.contributor.author.fl_str_mv Herbster, Suellen
Paladino, Andressa
Freitas, Sumara de
Boccardo, Enrique
dc.subject.por.fl_str_mv Human papillomavirus
Extracellular matrix
Matrix Metalloproteinases
TIMPs
RECK
topic Human papillomavirus
Extracellular matrix
Matrix Metalloproteinases
TIMPs
RECK
description Infection with human papillomaviruses is associated with a series of benign and malignant hyperproliferative diseases that impose a heavy burden on human populations. A subgroup of mucosal human papillomavirus types are associated with the majority of cervical cancers and a relevant fraction of vulvar, vaginal, anal, penile and head and neck carcinomas. Human papillomaviruses mediate cell transformation by the expression of two pleiotropic oncoproteins that alter major cellular regulatory pathways. However, these viruses are not complete carcinogens, and further alterations within the infected cells and in their microenvironment are necessary for tumor establishment and progression. Alterations in components of the extracellular matrix for instance, matrix metalloproteinases and some of their regulators such as tissue inhibitors of metalloproteinases, have been consistently reported in human papillomaviruses-associated diseases. Matrix metalloproteinases function by remodeling the extracellular matrix and alterations in their expression levels and/or activity are associated with pathological processes and clinical variables including local tumor invasion, metastasis, tumor relapse and overall patient prognosis and survival. In this review we present a summarized discussion on the current data concerning the impact of human papillomavirus infection on the activity and expression of extracellular matrix components. We further comment on the possibility of targeting extracellular matrix molecules in experimental treatment protocols.
publishDate 2019
dc.date.none.fl_str_mv 2019-02-15
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/154798
10.6061/clinics/2018/e551s
url https://www.revistas.usp.br/clinics/article/view/154798
identifier_str_mv 10.6061/clinics/2018/e551s
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/154798/150792
dc.rights.driver.fl_str_mv Copyright (c) 2019 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 73 No. Suppl. 1 (2018); e551s
Clinics; v. 73 n. Suppl. 1 (2018); e551s
Clinics; Vol. 73 Núm. Suppl. 1 (2018); e551s
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222763771756544